CAPPED BONUSZERTIFIKAT - ABBOTT LABORATORIES Stock

Certificat

DE000PC2NKU4

Market Closed - Boerse Frankfurt Warrants 03:40:16 2024-05-17 pm EDT
82.68 EUR -0.17% Intraday chart for CAPPED BONUSZERTIFIKAT - ABBOTT LABORATORIES
Current month-0.71%
1 month-0.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 82.73 -0.11%
24-05-16 82.82 +0.22%
24-05-15 82.64 -0.18%
24-05-14 82.79 -0.52%
24-05-13 83.22 -0.05%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC2NKU
ISINDE000PC2NKU4
Date issued 2023-12-22
Strike 100 $
Maturity 2025-12-19 (581 Days)
Parity 1 : 1
Emission price 76.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 84.1
Lowest since issue 79.28
Spread 0.05
Spread %0.06%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW